Replies to post #3960 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>DIC: It would be nice to see a PR regarding commencement of said LEO trial<

It would be, but I’m not sure that Leo wants to issue one. If they don’t, we might still be able to scope out some details about the trial from scanning the various databases for European clinical trials.

In any case, GTC will have to comment on the DIC trial during the 2Q07 CC in early August.